Central Composite Design for the Development and Evaluation of Floating-Mucoadhesive Tablets of Gliclazide

(E-pub Ahead of Print)

Author(s): Manoj Bansal, Ravinder Verma, Vineet Mittal, Deepak Kaushik*

Journal Name: Current Drug Therapy


Become EABM
Become Reviewer
Call for Editor

Abstract:

Background: Gliclazide assimilation rate from the gastrointestinal (GI) tract is slow and inconstant which may be either due to poor dissolution or poor permeability of the drug across the GI membrane.

Objective: The present investigation deals with the formulation of floating-mucoadhesive tablets of gliclazide for oral administration using central composite design by direct compression technique using HPMC K4M and Carbopol 934 as release controlling polymers and sodium bicarbonate as effervescent agent.

Methods: Central composite design was employed to quantify the effect of three factors-concentration of HPMC K4M (X1), concentration of Carbopol 934 (X2) and concentration of sodium bicarbonate (X3) on floating lag time, drug release and mucoadhesive time of the formulation.

Results: The results revealed that floating lag time decreases with rise in concentration of sodium bicarbonate, drug release was highest at low levels of HPMC and Carbopol and mucoadhesive time was highest at high level of Carbopol.

Conclusion: The optimized batch (F-7) shows mucoadhesive time of 23 minutes 27 seconds, floating lag time of 22 seconds and in vitro cumulative percentage of drug release 86.73 % in 10h. From the investigation, it can be summarized that the gastro-retentive drug delivery can be utilized to enhance bioavailability and gastric residence time of drugs.

Keywords: Central composite design, floating-mucoadhesive tablets, gliclazide, floating lag time, mucoadhesive time, in vitro drug release.

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1574885515999200623170251
Price: $95

Article Metrics

PDF: 1